-
3
-
-
0024380641
-
-
J Clin Pathol 1989;42:834-9.
-
Bayerdorffer E, Oertel H, Lehn N, Kasper G, Mannes GA, Sauerbruch T, et al. Topographie association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 1989;42:834-9.
-
Oertel H, Lehn N, Kasper G, Mannes GA, Sauerbruch T, et Al. Topographie Association between Active Gastritis and Campylobacter Pylori Colonisation.
-
-
Bayerdorffer, E.1
-
7
-
-
33746250456
-
-
Gastroenterology 1997;112:A200.
-
Lindt T, Bardhan KD, Bayerdorffer E, Helblom M, O'Morain C, Spiller RC, et al. The MACH 2 study: optimal Helicobacter pylori therapy needs omeprazole and can be reliably assessed by ÜBT. Gastroenterology 1997;112:A200.
-
Bardhan KD, Bayerdorffer E, Helblom M, O'Morain C, Spiller RC, et Al. the MACH 2 Study: Optimal Helicobacter Pylori Therapy Needs Omeprazole and Can Be Reliably Assessed by ÜBT.
-
-
Lindt, T.1
-
8
-
-
33746250764
-
-
London: WB Saunders, 1996:121-7.
-
Hua J, Birac C, Mégraud F. PCR-based RAPD 'fingerprinting' of clinical isolates of Helicobacter pylori. In: Lee A, Mégraud F, editors. Helicobacter pylori: Techniques for clinical diagnosis & basic research. London: WB Saunders, 1996:121-7.
-
Birac C, Mégraud F. PCR-based RAPD 'Fingerprinting' of Clinical Isolates of Helicobacter Pylori. In: Lee A, Mégraud F, Editors. Helicobacter Pylori: Techniques for Clinical Diagnosis & Basic Research.
-
-
Hua, J.1
-
9
-
-
0030068225
-
-
Antimicrob Agents Chemother 1996;40:477-80.
-
Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40:477-80.
-
Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, et Al. Mutations in 23S RRNA Are Associated with Clarithromycin Resistance in Helicobacter Pylori.
-
-
Versalovic, J.1
-
10
-
-
0030834006
-
-
Antimicrob Agents Chemoter 1997;41:2724-8.
-
Occhialini A, Urdaci M, Doucet-Populaire F, Bébéar C, Lamouliatte H, Mégraud F. Macrolide resistance in Helicobacter pylori: rapid detection of joint mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemoter 1997;41:2724-8.
-
Urdaci M, Doucet-Populaire F, Bébéar C, Lamouliatte H, Mégraud F. Macrolide Resistance in Helicobacter Pylori: Rapid Detection of Joint Mutations and Assays of Macrolide Binding to Ribosomes.
-
-
Occhialini, A.1
-
12
-
-
0030223132
-
-
Helicobacter 1996;l:138-44.
-
Lind T, van Zanten SV, Unge P, Spiller R, Bayerdorffer E, O'Morain C, et al. Eradication of Helicobacter pylori one-week triple therapies combining omeprazole with two antimicrobials: the MACH l study. Helicobacter 1996;l:138-44.
-
Van Zanten SV, Unge P, Spiller R, Bayerdorffer E, O'Morain C, et Al. Eradication of Helicobacter Pylori One-week Triple Therapies Combining Omeprazole with Two Antimicrobials: the MACH L Study.
-
-
Lind, T.1
-
13
-
-
9844242124
-
-
Aliment Pharmacol Ther 1997;! 1:943-52.
-
Wurzer H, Rodrigo L, Stamler D, Archambault A, Rokkas T, Skandalis N, et al. Short course therapy with amoxicillin-clarithromycin triple for 10 days (ACT 10) eradicates H. pylori and heals ulcer. Aliment Pharmacol Ther 1997;! 1:943-52.
-
Rodrigo L, Stamler D, Archambault A, Rokkas T, Skandalis N, et Al. Short Course Therapy with Amoxicillin-clarithromycin Triple for 10 Days (ACT 10) Eradicates H. Pylori and Heals Ulcer.
-
-
Wurzer, H.1
-
15
-
-
33746250451
-
-
Gastroenterology 1997;112:A216.
-
Mégraud F, Lehn N, Lind T, Bayerdorffer E, O'Morain C, Spiller RC et al. The Mach 2 study. Helicobacter pylori resistance to antimicrobiol agents and its influence on clinical outcome. Gastroenterology 1997;112:A216.
-
Lehn N, Lind T, Bayerdorffer E, O'Morain C, Spiller RC et Al. the Mach 2 Study. Helicobacter Pylori Resistance to Antimicrobiol Agents and Its Influence on Clinical Outcome.
-
-
Mégraud, F.1
-
19
-
-
0031031362
-
-
Eur J Gastroenterol Hepatol 1997;9:l-2.
-
Malfertheiner P, Mégraud F, O'Morain C, Bell D, Bianchi Porto G, Deltenre M, et al. Current European concepts in the management of Helicobacter pylori infection - the Maastricht consensus report. Eur J Gastroenterol Hepatol 1997;9:l-2.
-
Mégraud F, O'Morain C, Bell D, Bianchi Porto G, Deltenre M, et Al. Current European Concepts in the Management of Helicobacter Pylori Infection - the Maastricht Consensus Report.
-
-
Malfertheiner, P.1
|